Mahamaya Lifesciences
Listed
Listed
IPO Timeline
Issue open date
11 Nov 2025Issue close date
13 Nov 2025UPI mandate deadline
13 Nov 2025Allotment finalization
14 Nov 2025Refund initiation
17 Nov 2025Share credit
17 Nov 2025Listing date
18 Nov 2025Mandate end date
28 Nov 2025Lock-in end date for anchor investors (50%)
14 Dec 2025Lock-in end date for anchor investors (remaining)
12 Feb 2026Key Dates
Open
11 Nov 2025Close
13 Nov 2025Listing
18 Nov 2025Quick Stats
Issue Size:70cr
Lot Size:1200 shares
About the Company
Incorporated in 2002, Mahamaya Lifesciences is engaged in the manufacturing of pesticide formulations and bulk supplies for Indian agrochemical companies and multinational corporations. Headquartered in Delhi with a state-of-the-art manufacturing facility at Dahej, Gujarat, the company produces and markets both branded and bulk formulations domestically and internationally. Its products are sold across major Indian states and exported to markets including the Dominican Republic, Turkey, Egypt, and the UAE.
Strengths
- Wide portfolio of nutraceutical and herbal products for multiple therapeutic areas.
- ISO, GMP, and WHO-certified manufacturing facility ensuring quality standards.
- Experienced promoters with deep knowledge of pharma and healthcare sectors.
- Focus on R&D-driven product development for preventive health and wellness.
- Expanding distribution network across India and select export markets.
Risks
- Dependence on third-party distributors for sales and market reach.
- Intense competition in the nutraceutical and herbal segment.
- Regulatory changes in health product approvals may impact operations.
- Limited operating history as a public company under current structure.
- Raw material cost fluctuations may affect profitability.
Mahamaya Lifesciences IPO – Frequently Asked Questions
- The price band for the Mahamaya Lifesciences IPO is set at ₹108 to ₹114 per share.
- The Mahamaya Lifesciences IPO opens on November 11, 2025 and closes on November 13, 2025.
- The tentative listing date for the Mahamaya Lifesciences IPO is November 18, 2025.
- You can apply for the Mahamaya Lifesciences IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Mahamaya Lifesciences, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Mahamaya Lifesciences IPO is 1200 shares. Investors must apply for at least one lot (i.e., 1200 shares).